CFA Level I · Cheat Sheet
Equity Investments
EQUITY INVESTMENTS CHEAT SHEET
PORTER'S FIVE FORCES
Cue: Assess industry profitability and competitive intensity
| Force | High = Bad For Profitability | Low = Good For Profitability |
|---|---|---|
| Threat of New Entrants | Low barriers to entry | High barriers (scale, patents, capital, brand, switching costs) |
| Supplier Power | Few suppliers, can raise prices | Many suppliers, fragmented |
| Buyer Power | Few large buyers, price sensitive | Fragmented buyers, low price sensitivity |
| Threat of Substitutes | Good substitutes available | Few/no substitutes |
| Competitive Rivalry | Many competitors, commoditized products | Few competitors, differentiated products |
Rule: Weak all five forces → High sustainable margins (e.g., software, networks) Strong forces across multiple dimensions → Low industry profitability (e.g., airlines)
INDUSTRY LIFE CYCLE STAGES
| Stage | Growth | Competition | Margins | Valuation Approach |
|---|---|---|---|---|
| Embryonic | Slow, market developing | Few players, high failure risk | Low/negative | High growth assumptions, high risk |
| Growth | Rapid expansion | Increasing competitors attracted | Expanding | Higher multiples, reinvestment needs |
| Shakeout | Slowing growth | Intense, weaker players exit | Pressure | Risky; survivors have durable moats |
| Mature | Slow, stable (GDP-like) | Consolidated, stable rivalry | Stable | Modest multiples, focus on efficiency |
| Decline | Negative | Consolidation or exit | Compressed | Low multiples; terminal value near zero |
Key: Life cycle stage determines competitive dynamics, capital intensity, and appropriate valuation multiples.
COMPETITIVE ADVANTAGE (ECONOMIC MOAT) SOURCES
Cue: Identifies sustainable excess returns above cost of capital
| Source | Definition | Example | Durability |
|---|---|---|---|
| Cost Advantages | Scale economies, proprietary tech, low-cost inputs | Intel chip manufacturing, Walmart sourcing | Medium-High |
| Intangible Assets | Patents, brands, licenses, regulatory approval | Pharma patents, branded pharmaceuticals | High if renewed/protected |
| Switching Costs | Customer lock-in (embedded software, loyalty) | Enterprise software, payment networks | High |
| Network Effects | Value increases with # users (two-sided markets) | Visa/Mastercard, LinkedIn, Uber | Very High |
| Efficient Scale | Natural monopoly in limited market | Regional utility, local telecom | High if uncontested |
Key Metric: Competitive Advantage Period (CAP) = Years firm can sustain excess returns → directly impacts intrinsic value premium over book value
FINANCIAL FORECASTING FOR DCF
Revenue Forecast:
- Top-down: Industry size × Company market share
- Bottom-up: Historical growth adjusted for industry/competitive factors
Operating Margin Projection:
- Use industry benchmarks + company-specific cost structure
- Account for operating leverage, scale effects
Terminal Value (Most Critical): $$\text{Terminal Value} = \frac{\text{Final Year FCF} \times (1 + g)}{WACC - g}$$
| Assumption | Typical Range | Risk |
|---|---|---|
| Terminal growth rate (g) | 2–3% GDP-like for mature | Overly optimistic g → inflates value |
| WACC | 6–10% depending on risk | WACC changes dominate TV |
Rule: Terminal value typically = 60–80% of total DCF value → Run sensitivity analysis on g and WACC
INDEX WEIGHTING METHODOLOGIES
| Type | Weight by | Bias | Maintenance |
|---|---|---|---|
| Price-Weighted | Stock price per share | Favors high-priced stocks (unrelated to size); stock splits distort | Infrequent rebalancing |
| Market-Cap-Weighted | Market capitalization | Momentum bias (winners get heavier); concentration risk | Passive drift |
| Float-Adjusted | Tradeable shares only | More representative; excludes insider/gov blocks | Passive drift |
| Equal-Weighted | Same weight all constituents | Value tilt (rebalancing sells winners, buys losers) | Frequent rebalancing |
Implication: Market-cap indices passively overweight stocks that have already rallied; equal-weighted indices provide rebalancing benefit but higher costs.
HIGH-YIELD FORMULAS
$$\text{Market Cap} = \text{Price per Share} \times \text{Shares Outstanding}$$
$$\text{Revenue Growth (top-down)} = \text{Industry Growth} \times \text{Market Share Change}$$
$$\text{Terminal Value} = \text{FCF}_\text{final} \times \frac{1+g}{WACC - g}$$
$$\text{PV} = \frac{\text{Cash Flow}}{(1 + r)^n}$$
EASILY-CONFUSED PAIRS
| Concept A | Concept B | Key Difference |
|---|---|---|
| Switching Costs | Network Effects | Switching: I'm locked in because leaving is painful. Network: System becomes more valuable as more users join. |
| Barriers to Entry | Competitive Advantage Period | Entry barriers: Why new competitors can't easily enter. CAP: How long incumbent can earn excess returns. |
| Price-Weighted Index | Equal-Weighted Index | Price: High-priced stock dominates (unrelated to size). Equal: All stocks same weight; requires active rebalancing. |
| Mature Stage | Declining Stage | Mature: Stable slow growth, consolidated structure. Declining: Negative growth, disruption or demand loss. |
EXAM QUICK HITS
✓ Patent cliff = pharmaceutical CAP terminus; triggers dramatic margin collapse ✓ Two-sided network effects (e.g., Visa
Aligned to the standard reference materials.
Make this cheat sheet yours
Personalize this sheet — focus it however you study, or build one from the exact questions you keep getting wrong.